3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Signs and Symptoms
1
Psoriasis
1
Nutrition Disorders
1
Insulin Resistance
1
Inflammatory Bowel Diseases
1
Glioma
1
Glioblastoma
1
Gastroparesis
1
Feeding and Eating Disorders
1
Esophageal Neoplasms
1
Dumping Syndrome
1
Diarrhea
1
Breast Neoplasms
1
Brain Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Cisplatin
90
Fluorouracil
76
Radiotherapy
63
Paclitaxel
58
Docetaxel
49
Oxaliplatin
48
Irinotecan
42
Leucovorin
32
Capecitabine
31
Carboplatin
27
Radiation
21
Surgical Procedures, Operative
20
Esophagectomy
20
pembrolizumab
15
Neoadjuvant Therapy
15
Bevacizumab
15
Cetuximab
13
Drug Therapy
12
Epirubicin
11
Chemotherapy, Adjuvant
9
S 1 (combination)
8
Magnetic Resonance Spectroscopy
8
Gemcitabine
8
Trastuzumab
7
Nivolumab
7
Erlotinib Hydrochloride
7
Surveys and Questionnaires
6
Panitumumab
6
Immunohistochemistry
6
Chemoradiotherapy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Esophageal Neoplasms
×
Sulfasalazine
×
Clear all
NCT03734627
2021-08-16
EndoGut
St. James's Hospital, Ireland
Completed
40 enrolled